HRP20180500T1 - Kristalni polimorf selektivnih modulatora androgena (r) ili (s)-n-(4-cijano-3-(trifluorometil)fenil)-3-(4-cijanofenoksi)-2-hidroksi-2-metilpropanamida - Google Patents
Kristalni polimorf selektivnih modulatora androgena (r) ili (s)-n-(4-cijano-3-(trifluorometil)fenil)-3-(4-cijanofenoksi)-2-hidroksi-2-metilpropanamidaInfo
- Publication number
- HRP20180500T1 HRP20180500T1 HRP20180500TT HRP20180500T HRP20180500T1 HR P20180500 T1 HRP20180500 T1 HR P20180500T1 HR P20180500T T HRP20180500T T HR P20180500TT HR P20180500 T HRP20180500 T HR P20180500T HR P20180500 T1 HRP20180500 T1 HR P20180500T1
- Authority
- HR
- Croatia
- Prior art keywords
- methylpropanamide
- cyanophenoxy
- trifluoromethyl
- cyano
- hydroxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
- C07C255/60—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96001207P | 2007-09-11 | 2007-09-11 | |
PCT/US2008/076066 WO2009036206A1 (en) | 2007-09-11 | 2008-09-11 | Solid forms of selective androgen receptor modulators |
EP08799476.0A EP2205552B1 (en) | 2007-09-11 | 2008-09-11 | Crystalline polymorph of the selective androgen modulators (r) or (s)-n-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20180500T1 true HRP20180500T1 (hr) | 2018-06-01 |
Family
ID=40452483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20180500TT HRP20180500T1 (hr) | 2007-09-11 | 2018-03-27 | Kristalni polimorf selektivnih modulatora androgena (r) ili (s)-n-(4-cijano-3-(trifluorometil)fenil)-3-(4-cijanofenoksi)-2-hidroksi-2-metilpropanamida |
Country Status (20)
Country | Link |
---|---|
US (1) | US7977386B2 (hr) |
EP (2) | EP2205552B1 (hr) |
JP (3) | JP5452492B2 (hr) |
KR (3) | KR20170001736A (hr) |
CN (3) | CN101855198B (hr) |
AU (1) | AU2008298901C1 (hr) |
CA (3) | CA2886498C (hr) |
CY (1) | CY1120107T1 (hr) |
DK (1) | DK2205552T3 (hr) |
EA (1) | EA018611B1 (hr) |
ES (1) | ES2665007T3 (hr) |
HR (1) | HRP20180500T1 (hr) |
HU (1) | HUE036762T2 (hr) |
IL (2) | IL204352A (hr) |
LT (1) | LT2205552T (hr) |
MX (6) | MX341090B (hr) |
NO (1) | NO2205552T3 (hr) |
PL (1) | PL2205552T3 (hr) |
PT (1) | PT2205552T (hr) |
WO (1) | WO2009036206A1 (hr) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7855229B2 (en) * | 2000-08-24 | 2010-12-21 | University Of Tennessee Research Foundation | Treating wasting disorders with selective androgen receptor modulators |
US7919647B2 (en) | 2000-08-24 | 2011-04-05 | University Of Tennessee Research Foundation | Selective androgen receptor modulators and methods of use thereof |
US20070161608A1 (en) * | 2001-12-06 | 2007-07-12 | Dalton James T | Selective androgen receptor modulators for treating muscle wasting |
US8853266B2 (en) * | 2001-12-06 | 2014-10-07 | University Of Tennessee Research Foundation | Selective androgen receptor modulators for treating diabetes |
US9889110B2 (en) | 2004-06-07 | 2018-02-13 | University Of Tennessee Research Foundation | Selective androgen receptor modulator for treating hormone-related conditions |
US20110237664A1 (en) * | 2004-06-07 | 2011-09-29 | Dalton James T | Selective androgen receptor modulators for treating diabetes |
US9884038B2 (en) | 2004-06-07 | 2018-02-06 | University Of Tennessee Research Foundation | Selective androgen receptor modulator and methods of use thereof |
US10010521B2 (en) | 2006-08-24 | 2018-07-03 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
US9844528B2 (en) | 2006-08-24 | 2017-12-19 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
US9730908B2 (en) | 2006-08-24 | 2017-08-15 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
US7968603B2 (en) | 2007-09-11 | 2011-06-28 | University Of Tennessee Research Foundation | Solid forms of selective androgen receptor modulators |
KR20170001736A (ko) * | 2007-09-11 | 2017-01-04 | 지티엑스, 인코포레이티드 | 고형의 선택적인 안드로겐 수용체 모듈레이터 |
CN103002737A (zh) * | 2010-01-11 | 2013-03-27 | Gtx公司 | 治疗睑板腺功能障碍的方法 |
US10987334B2 (en) | 2012-07-13 | 2021-04-27 | University Of Tennessee Research Foundation | Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs) |
US10314807B2 (en) | 2012-07-13 | 2019-06-11 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
US9622992B2 (en) | 2012-07-13 | 2017-04-18 | Gtx, Inc. | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) |
US9744149B2 (en) | 2012-07-13 | 2017-08-29 | Gtx, Inc. | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) |
DK2872482T3 (da) | 2012-07-13 | 2020-09-21 | Oncternal Therapeutics Inc | En fremgangsmåde til behandling af brystkræft med selektiv androgenreceptormodulator (sarm) |
US10258596B2 (en) | 2012-07-13 | 2019-04-16 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
US9969683B2 (en) | 2012-07-13 | 2018-05-15 | Gtx, Inc. | Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS) |
TWI726969B (zh) | 2016-01-11 | 2021-05-11 | 比利時商健生藥品公司 | 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物 |
CN110563607B (zh) * | 2019-10-25 | 2022-07-08 | 许昌远志生物科技有限公司 | 一种mk-2866的精制方法 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050038110A1 (en) | 2000-08-24 | 2005-02-17 | Steiner Mitchell S. | Selective androgen receptor modulators and methods of use thereof |
US7026500B2 (en) * | 2000-08-24 | 2006-04-11 | University Of Tennessee Research Foundation | Halogenated selective androgen receptor modulators and methods of use thereof |
US7645898B2 (en) * | 2000-08-24 | 2010-01-12 | University Of Tennessee Research Foundation | Selective androgen receptor modulators and method of use thereof |
EP1401801B1 (en) * | 2000-08-24 | 2006-11-02 | The University Of Tennessee Research Corporation | Selective androgen receptor modulators and methods of use thereof |
US7855229B2 (en) | 2000-08-24 | 2010-12-21 | University Of Tennessee Research Foundation | Treating wasting disorders with selective androgen receptor modulators |
US20070173546A1 (en) * | 2000-08-24 | 2007-07-26 | Dalton James T | Selective androgen receptor modulators and method of use thereof |
US7622503B2 (en) | 2000-08-24 | 2009-11-24 | University Of Tennessee Research Foundation | Selective androgen receptor modulators and methods of use thereof |
US7919647B2 (en) | 2000-08-24 | 2011-04-05 | University Of Tennessee Research Foundation | Selective androgen receptor modulators and methods of use thereof |
CZ2003836A3 (cs) * | 2000-09-21 | 2003-08-13 | Bristol-Myers Squibb Company | Způsob přípravy N-(substituovaný fenyl)-3-alkyl,-aryl- a -heteroarylsulfonyl-2-hydroxy-2-alkyl-a -halogenalkylpropanamidových sloučenin |
US8853266B2 (en) | 2001-12-06 | 2014-10-07 | University Of Tennessee Research Foundation | Selective androgen receptor modulators for treating diabetes |
US20070161608A1 (en) * | 2001-12-06 | 2007-07-12 | Dalton James T | Selective androgen receptor modulators for treating muscle wasting |
EP2289503B1 (en) * | 2001-12-06 | 2016-06-29 | University of Tennessee Research Foundation | Treating muscle wasting with selective androgen receptor modulators |
US7705182B2 (en) * | 2002-02-28 | 2010-04-27 | University Of Tennessee Research Foundation | Multi-substituted selective androgen receptor modulators and methods of use thereof |
AU2003287077B2 (en) * | 2002-10-15 | 2007-09-20 | University Of Tennessee Research Foundation | Methylene-bridged selective androgen receptor modulators and methods of use thereof |
CA2513242C (en) * | 2003-01-13 | 2013-07-09 | Gtx Inc. | Large-scale synthesis of selective androgen receptor modulators |
EA013738B1 (ru) | 2003-10-14 | 2010-06-30 | Юниверсити Оф Теннесси Рисерч Фаундейшн | Лечение нарушений костной ткани с использованием селективных модуляторов адрогенных рецепторов |
JP2009506119A (ja) | 2005-08-31 | 2009-02-12 | ユニバーシティ オブ テネシー リサーチ ファウンデーション | 選択的アンドロゲン受容体モジュレーターを用いる腎疾患、熱傷、創傷および脊髄損傷の処置 |
TW200730505A (en) | 2005-12-07 | 2007-08-16 | Merck & Co Inc | Polymorphs of an androgen receptor modulator |
CN1825959A (zh) * | 2006-03-02 | 2006-08-30 | 复旦大学 | 一种基于自适应多步搜索的图像跟踪算法 |
US7968603B2 (en) * | 2007-09-11 | 2011-06-28 | University Of Tennessee Research Foundation | Solid forms of selective androgen receptor modulators |
KR20170001736A (ko) * | 2007-09-11 | 2017-01-04 | 지티엑스, 인코포레이티드 | 고형의 선택적인 안드로겐 수용체 모듈레이터 |
-
2008
- 2008-09-11 KR KR1020167036280A patent/KR20170001736A/ko not_active Application Discontinuation
- 2008-09-11 EP EP08799476.0A patent/EP2205552B1/en active Active
- 2008-09-11 EA EA201070350A patent/EA018611B1/ru not_active IP Right Cessation
- 2008-09-11 KR KR1020107007825A patent/KR101580905B1/ko active IP Right Grant
- 2008-09-11 MX MX2012013650A patent/MX341090B/es unknown
- 2008-09-11 CN CN2008801155337A patent/CN101855198B/zh active Active
- 2008-09-11 CN CN201310308688.5A patent/CN103553966B/zh active Active
- 2008-09-11 NO NO08799476A patent/NO2205552T3/no unknown
- 2008-09-11 DK DK08799476.0T patent/DK2205552T3/en active
- 2008-09-11 LT LTEP08799476.0T patent/LT2205552T/lt unknown
- 2008-09-11 JP JP2010524998A patent/JP5452492B2/ja active Active
- 2008-09-11 CA CA2886498A patent/CA2886498C/en active Active
- 2008-09-11 CA CA2886501A patent/CA2886501C/en active Active
- 2008-09-11 HU HUE08799476A patent/HUE036762T2/hu unknown
- 2008-09-11 CA CA2709118A patent/CA2709118C/en active Active
- 2008-09-11 PL PL08799476T patent/PL2205552T3/pl unknown
- 2008-09-11 WO PCT/US2008/076066 patent/WO2009036206A1/en active Application Filing
- 2008-09-11 ES ES08799476.0T patent/ES2665007T3/es active Active
- 2008-09-11 MX MX2012013653A patent/MX336760B/es unknown
- 2008-09-11 KR KR1020157036209A patent/KR101691877B1/ko active IP Right Grant
- 2008-09-11 US US12/209,137 patent/US7977386B2/en active Active
- 2008-09-11 MX MX2017007289A patent/MX360801B/es unknown
- 2008-09-11 MX MX2010002784A patent/MX2010002784A/es active IP Right Grant
- 2008-09-11 CN CN201210530104.4A patent/CN103073450B/zh active Active
- 2008-09-11 PT PT87994760T patent/PT2205552T/pt unknown
- 2008-09-11 AU AU2008298901A patent/AU2008298901C1/en active Active
- 2008-09-11 EP EP14190028.2A patent/EP2871177B1/en active Active
- 2008-09-11 MX MX2016010097A patent/MX351941B/es unknown
-
2010
- 2010-03-08 IL IL204352A patent/IL204352A/en active IP Right Grant
- 2010-03-11 MX MX2018014065A patent/MX2018014065A/es unknown
-
2011
- 2011-11-10 JP JP2011246394A patent/JP5599380B2/ja active Active
-
2014
- 2014-01-17 JP JP2014006976A patent/JP5727636B2/ja active Active
-
2017
- 2017-03-30 IL IL251483A patent/IL251483A0/en active IP Right Grant
-
2018
- 2018-03-27 HR HRP20180500TT patent/HRP20180500T1/hr unknown
- 2018-03-30 CY CY20181100359T patent/CY1120107T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20180500T1 (hr) | Kristalni polimorf selektivnih modulatora androgena (r) ili (s)-n-(4-cijano-3-(trifluorometil)fenil)-3-(4-cijanofenoksi)-2-hidroksi-2-metilpropanamida | |
IL242538A (en) | Composition containing (s) –n– (3– chloro – 4 – cyanophenyl) –3– (4 – cyanophenoxy) -2 | |
PL1846566T3 (pl) | Stabilne kryształy natamycyny o kształcie igiełkowatym | |
IL244442A0 (en) | Compounds of converted acylanilides and their use | |
SI2097381T1 (sl) | 4-(4-((4-kloro-3-(trifluorometil)fenil))karbamoil)amino)-3- fluorofenoksi)-n-metilpiridin-2-karbokasamid monohidrat | |
PL1636190T3 (pl) | Trwały kryształ związku 4-oksochinoliny | |
IL202508A0 (en) | Benzamide mglur5 positive allosteric modulators and methods of making and using the same | |
EP1953151A4 (en) | SALTS FROM A CYNNAMIDE COMPOUND OR SOLVATE THEREOF | |
GB0714030D0 (en) | The use of type-B lantibiotic-based compounds having antimicrobial activity | |
ZA200808182B (en) | Herbicidal mixture comprising diuron and mesotrione | |
DK2117525T3 (da) | Anvendelse af 1-phenyl-3-dimethylamino-propanforbindelser til behandling af neuropatismerte | |
IL181297A0 (en) | Benzamide compounds | |
IL196432A0 (en) | Nanoparticulate formulations of modafinil | |
IL191052A0 (en) | Process for the preparation of tamsulosin and related compounds | |
HK1223606A1 (zh) | 三氟甲基 苯甲基 -甲氧基丁醯胺的多晶型物 | |
EP1889841A4 (en) | CRYSTAL OF A SALT OF A BENZIMIDAZOLE COMPOUND | |
GB0604772D0 (en) | Use of substituted amine compounds for the treatment of food related disorders | |
ZA200701801B (en) | Benzamide compounds | |
ITMI20061606A1 (it) | Procedimento per la preparazione di composti nitrilici | |
PT2374897E (pt) | Cristais estáveis de natamicina em forma de agulha | |
ZA200900186B (en) | Nanoparticulate formulations of modafinil | |
GB0506165D0 (en) | Benzamide compounds | |
PL371955A1 (pl) | Preparat florfenikolu do zastosowań weterynaryjnych |